Levothyroxine Sodium Tablet
Product Images NDC 51655-997

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)

Chemical structure of Levothyroxine Sodium showing its molecular composition, including iodine atoms, hydroxyl groups, and amine functional group along with a sodium ion and water molecule association.*

FDA Label Image

Label (51655 997 52 Master Bottle Label Approval Rev A 06 22)

Label for Levothyroxine Sodium Tablets, USP 112 mcg (0.112 mg), oral tablets. The package contains 30 tablets and is labeled for prescription use only. Storage instructions include keeping the product at 25°C (77°F) with permitted excursions between 15°-30°C (59°-86°F), protected from light and moisture, and out of reach of children. The labeler is Northwind Health Company, LLC, with NDC 51655-997-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.